713 related articles for article (PubMed ID: 15585882)
21. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
22. TLR2 and TLR4 stimulation differentially induce cytokine secretion in human neonatal, adult, and murine mononuclear cells.
Schaub B; Bellou A; Gibbons FK; Velasco G; Campo M; He H; Liang Y; Gillman MW; Gold D; Weiss ST; Perkins DL; Finn PW
J Interferon Cytokine Res; 2004 Sep; 24(9):543-52. PubMed ID: 15450130
[TBL] [Abstract][Full Text] [Related]
23. TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation.
Qian C; An H; Yu Y; Liu S; Cao X
Blood; 2007 Apr; 109(8):3308-15. PubMed ID: 17170125
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan.
Uehori J; Matsumoto M; Tsuji S; Akazawa T; Takeuchi O; Akira S; Kawata T; Azuma I; Toyoshima K; Seya T
Infect Immun; 2003 Aug; 71(8):4238-49. PubMed ID: 12874299
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.
Higgins SC; Lavelle EC; McCann C; Keogh B; McNeela E; Byrne P; O'Gorman B; Jarnicki A; McGuirk P; Mills KH
J Immunol; 2003 Sep; 171(6):3119-27. PubMed ID: 12960338
[TBL] [Abstract][Full Text] [Related]
26. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10.
Thoma-Uszynski S; Kiertscher SM; Ochoa MT; Bouis DA; Norgard MV; Miyake K; Godowski PJ; Roth MD; Modlin RL
J Immunol; 2000 Oct; 165(7):3804-10. PubMed ID: 11034386
[TBL] [Abstract][Full Text] [Related]
27. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists.
Werling D; Hope JC; Howard CJ; Jungi TW
Immunology; 2004 Jan; 111(1):41-52. PubMed ID: 14678198
[TBL] [Abstract][Full Text] [Related]
28. Human monocytoid cells as a model to study Toll-like receptor-mediated activation.
Remer KA; Brcic M; Sauter KS; Jungi TW
J Immunol Methods; 2006 Jun; 313(1-2):1-10. PubMed ID: 16720029
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.
Kamath AT; Sheasby CE; Tough DF
J Immunol; 2005 Jan; 174(2):767-76. PubMed ID: 15634897
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells.
Re F; Strominger JL
J Biol Chem; 2001 Oct; 276(40):37692-9. PubMed ID: 11477091
[TBL] [Abstract][Full Text] [Related]
32. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
[TBL] [Abstract][Full Text] [Related]
34. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
35. Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state.
Hume DA; Underhill DM; Sweet MJ; Ozinsky AO; Liew FY; Aderem A
BMC Immunol; 2001; 2():11. PubMed ID: 11686851
[TBL] [Abstract][Full Text] [Related]
36. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
[TBL] [Abstract][Full Text] [Related]
37. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
[TBL] [Abstract][Full Text] [Related]
38. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
[TBL] [Abstract][Full Text] [Related]
39. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
40. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.
Kadowaki N; Ho S; Antonenko S; Malefyt RW; Kastelein RA; Bazan F; Liu YJ
J Exp Med; 2001 Sep; 194(6):863-9. PubMed ID: 11561001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
